;PMID: 3030702
;source_file_890.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..38] = [t:0..37]
;1)sentence:[e:44..90] = [t:44..90]
;2)section:[e:94..127] = [t:94..126]
;3)sentence:[e:131..257] = [t:131..257]
;4)sentence:[e:258..350] = [t:258..350]
;5)sentence:[e:351..470] = [t:351..470]
;6)sentence:[e:471..611] = [t:471..611]
;7)sentence:[e:612..787] = [t:612..787]
;8)sentence:[e:788..856] = [t:788..856]
;9)sentence:[e:857..954] = [t:857..954]
;10)sentence:[e:955..1162] = [t:955..1162]
;11)sentence:[e:1163..1269] = [t:1163..1269]
;12)sentence:[e:1270..1366] = [t:1270..1366]
;13)sentence:[e:1367..1541] = [t:1367..1541]
;14)sentence:[e:1542..1661] = [t:1542..1661]
;15)section:[e:1665..1709] = [t:1665..1708]
;Sentence Matching Errors
;ERROR_Section end mismatch[e:0..38][t:0..37]
;ERROR_Section end mismatch[e:94..127][t:94..126]
;ERROR_Section end mismatch[e:1665..1709][t:1665..1708]
;Token/POS Errors
;ERROR_Token in entity file but not tree[37..38] .
;ERROR_Token in entity file but not tree[126..127] .
;ERROR_Token in entity file but not tree[524..526] [1
;ERROR_Token in entity file but not tree[528..537] beta-3H]T
;ERROR_Token in entity file but not tree[1708..1709] ]
;ERROR_Token in tree file but not entity[524..537] [1beta-3H]T

;section 0 Span:0..37
;Endocrinology. 1987 Apr;120(4):1482-9
(SEC
  (FRAG (NNP:[0..13] Endocrinology) (IN:[13..14] .) (CD:[15..19] 1987)
        (NNP:[20..23] Apr) (::[23..24] ;) (CD:[24..27] 120)
        (-LRB-:[27..28] -LRB-) (CD:[28..29] 4) (-RRB-:[29..30] -RRB-)
        (::[30..31] :) (CD:[31..35] 1482) (::[35..36] -) (CD:[36..37] 9)))

(ORPH .)

;sentence 1 Span:44..90
;Aromatase activity in a rat Leydig cell tumor.
;[44..53]:cyp450:"Aromatase"
(SENT
  (NP-HLN
    (NP-SBJ (NN:[44..53] Aromatase) (NN:[54..62] activity))
    (PP-LOC (IN:[63..65] in)
      (NP (DT:[66..67] a) (NN:[68..71] rat)
        (NML (NNP:[72..78] Leydig) (NN:[79..83] cell))
        (NN:[84..89] tumor)))
    (.:[89..90] .)))
;ERROR_Orphan Text from Tree File[37..44] .

;section 2 Span:94..126
;Orczyk GP, Mordes JP, Longcope C
(SEC
  (FRAG (NNP:[94..100] Orczyk) (NNP:[101..103] GP) (,:[103..104] ,)
        (NNP:[105..111] Mordes) (NNP:[112..114] JP) (,:[114..115] ,)
        (NNP:[116..124] Longcope) (NNP:[125..126] C)))

(ORPH .)

;sentence 3 Span:131..257
;Male Wistar-Furth rats bearing the transplantable LTW(m) Leydig cell tumor
;have  elevated serum estradiol (E2) concentrations.
;[227..236]:substance:"estradiol"
;[238..240]:substance:"E2"
(SENT
  (S
    (NP-SBJ
      (NP (JJ:[131..135] Male)
        (NML (NNP:[136..142] Wistar) (HYPH:[142..143] -) (NNP:[143..148] Furth))
        (NNS:[149..153] rats))
      (VP (VBG:[154..161] bearing)
        (NP (DT:[162..165] the) (JJ:[166..180] transplantable)
          (NML (NN:[181..184] LTW) (-LRB-:[184..185] -LRB-) (NN:[185..186] m)
               (-RRB-:[186..187] -RRB-))
          (NML (NNP:[188..194] Leydig) (NN:[195..199] cell))
          (NN:[200..205] tumor))))
    (VP (VBP:[206..210] have)
      (NP (JJ:[212..220] elevated) (NN:[221..226] serum)
        (NML
          (NML (NN:[227..236] estradiol))
          (NML (-LRB-:[237..238] -LRB-) (NN:[238..240] E2)
               (-RRB-:[240..241] -RRB-)))
        (NNS:[242..256] concentrations)))
    (.:[256..257] .)))
;ERROR_Orphan Text from Tree File[126..131] .

;sentence 4 Span:258..350
;We measured the ability of these  tumors to aromatize testosterone (T) to E2
;by two methods.
;[312..324]:substance:"testosterone"
;[326..327]:substance:"T"
;[332..334]:substance:"E2"
(SENT
  (S
    (NP-SBJ (PRP:[258..260] We))
    (VP (VBD:[261..269] measured)
      (NP
        (NP (DT:[270..273] the) (NN:[274..281] ability)
          (S-1 (-NONE-:[281..281] *ICH*)))
        (PP (IN:[282..284] of)
          (NP (DT:[285..290] these) (NNS:[292..298] tumors)))
        (S-1
          (NP-SBJ (-NONE-:[298..298] *))
          (VP (TO:[299..301] to)
            (VP (VB:[302..311] aromatize)
              (NP
                (NP (NN:[312..324] testosterone))
                (NP (-LRB-:[325..326] -LRB-) (NN:[326..327] T)
                    (-RRB-:[327..328] -RRB-)))
              (PP (TO:[329..331] to)
                (NP (NN:[332..334] E2)))))))
      (PP-MNR (IN:[335..337] by)
        (NP (CD:[338..341] two) (NNS:[342..349] methods))))
    (.:[349..350] .)))

;sentence 5 Span:351..470
;First, tumor minces  were incubated with [7-3H]T, and the resultant [3H]E2
;and [3H]estrone were  purified and measured.
;[392..399]:substance:"[7-3H]T"
;[419..425]:substance:"[3H]E2"
;[430..441]:substance:"[3H]estrone"
(SENT
  (S
    (S
      (ADVP (RB:[351..356] First))
      (,:[356..357] ,)
      (NP-SBJ-2 (NN:[358..363] tumor) (NNS:[364..370] minces))
      (VP (VBD:[372..376] were)
        (VP (VBN:[377..386] incubated)
          (NP-2 (-NONE-:[386..386] *))
          (PP-MNR (IN:[387..391] with)
            (NP (NN:[392..399] -LSB-7-3H-RSB-T))))))
    (,:[399..400] ,) (CC:[401..404] and)
    (S
      (NP-SBJ-1 (DT:[405..408] the) (JJ:[409..418] resultant)
                (NN:[419..425] -LSB-3H-RSB-E2) (CC:[426..429] and)
                (NN:[430..441] -LSB-3H-RSB-estrone))
      (VP (VBD:[442..446] were)
        (VP (VBN:[448..456] purified) (CC:[457..460] and)
            (VBN:[461..469] measured)
          (NP-1 (-NONE-:[469..469] *)))))
    (.:[469..470] .)))

;sentence 6 Span:471..611
;In addition, tumor cell cultures were incubated with [1  beta-3H]T, and the
;resultant [3H]H2O was determined as a measure of  aromatization.
;[524..537]:substance:"[1  beta-3H]T"
;[557..564]:substance:"[3H]H2O"
(SENT
  (S
    (S
      (PP (IN:[471..473] In)
        (NP (NN:[474..482] addition)))
      (,:[482..483] ,)
      (NP-SBJ-2 (NN:[484..489] tumor) (NN:[490..494] cell)
                (NNS:[495..503] cultures))
      (VP (VBD:[504..508] were)
        (VP (VBN:[509..518] incubated)
          (NP-2 (-NONE-:[518..518] *))
          (PP-MNR (IN:[519..523] with)
            (NP (NN:[524..537] -LSB-1beta-3H-RSB-T))))))
    (,:[537..538] ,) (CC:[539..542] and)
    (S
      (NP-SBJ-1 (DT:[543..546] the) (JJ:[547..556] resultant)
                (NN:[557..564] -LSB-3H-RSB-H2O))
      (VP (VBD:[565..568] was)
        (VP (VBN:[569..579] determined)
          (NP-1 (-NONE-:[579..579] *))
          (PP (IN:[580..582] as)
            (NP
              (NP (DT:[583..584] a) (NN:[585..592] measure))
              (PP (IN:[593..595] of)
                (NP (NN:[597..610] aromatization))))))))
    (.:[610..611] .)))

;sentence 7 Span:612..787
;Tumor minces aromatized more actively than normal rat testicular  tissue
;(3.30 +/- 0.15% of the T added was converted to E2 by the tumor vs. 0.30  +/-
;0.25% by normal testis).
;[686..700]:quantitative-value:"3.30 +/- 0.15%"
;[708..709]:substance:"T"
;[733..735]:substance:"E2"
;[753..768]:quantitative-value:"0.30  +/- 0.25%"
(SENT
  (S
    (NP-SBJ (NN:[612..617] Tumor) (NNS:[618..624] minces))
    (VP (VBD:[625..635] aromatized)
      (ADVP
        (ADVP (RBR:[636..640] more) (RB:[641..649] actively))
        (PP (IN:[650..654] than)
          (NP (JJ:[655..661] normal) (NN:[662..665] rat)
              (JJ:[666..676] testicular) (NN:[678..684] tissue))))
      (PRN (-LRB-:[685..686] -LRB-)
        (S
          (S
            (NP-SBJ-1=2
              (NP
                (QP (CD:[686..690] 3.30) (SYM:[691..694] +/-)
                    (CD:[695..699] 0.15))
                (NN:[699..700] %))
              (PP (IN:[701..703] of)
                (NP
                  (NP (DT:[704..707] the) (NN:[708..709] T))
                  (VP (VBN:[710..715] added)
                    (NP (-NONE-:[715..715] *))))))
            (VP (VBD:[716..719] was)
              (VP (VBN:[720..729] converted)
                (NP-1 (-NONE-:[729..729] *))
                (PP-CLR (TO:[730..732] to)
                  (NP (NN:[733..735] E2)))
                (PP=3 (IN:[736..738] by)
                  (NP-LGS (DT:[739..742] the) (NN:[743..748] tumor))))))
          (IN:[749..752] vs.)
          (S
            (NP-SBJ=2
              (QP (CD:[753..757] 0.30) (SYM:[759..762] +/-) (CD:[763..767] 0.25))
              (NN:[767..768] %))
            (PP=3 (IN:[769..771] by)
              (NP-LGS (JJ:[772..778] normal) (NN:[779..785] testis)))))
        (-RRB-:[785..786] -RRB-)))
    (.:[786..787] .)))

;sentence 8 Span:788..856
;Most of the aromatizing actitivity was localized to  the microsomes.
(SENT
  (S
    (NP-SBJ-1
      (NP (JJS:[788..792] Most))
      (PP (IN:[793..795] of)
        (NP (DT:[796..799] the) (NN:[800..811] aromatizing)
            (NN:[812..822] actitivity))))
    (VP (VBD:[823..826] was)
      (VP (VBN:[827..836] localized)
        (NP-1 (-NONE-:[836..836] *))
        (PP (TO:[837..839] to)
          (NP (DT:[841..844] the) (NNS:[845..855] microsomes)))))
    (.:[855..856] .)))

;sentence 9 Span:857..954
;Using cell cultures the maximum velocity was 6.1 pmol/h X 5 X  10(5) cells,
;and the Km was 98 nM.
;[881..897]:quantitative-name:"maximum velocity"
;[902..905]:quantitative-value:"6.1"
;[906..931]:quantitative-units:"pmol/h X 5 X  10(5) cells"
;[941..943]:quantitative-name:"Km"
;[948..950]:quantitative-value:"98"
;[951..953]:quantitative-units:"nM"
(SENT
  (S
    (S
      (S-ADV
        (NP-SBJ (-NONE-:[857..857] *))
        (VP (VBG:[857..862] Using)
          (NP (NN:[863..867] cell) (NNS:[868..876] cultures))))
      (NP-SBJ (DT:[877..880] the)
         (JJ:[881..888] maximum) (NN:[889..897] velocity))
      (VP (VBD:[898..901] was)
        (NP-PRD
          (NP (CD:[902..905] 6.1) (NN:[906..910] pmol))
          (PP (SYM:[910..911] /)
            (NP (NN:[911..912] h)))
          (PP (SYM:[913..914] X)
            (NP
              (QP (CD:[915..916] 5) (SYM:[917..918] X)
                  (CD:[920..925] 10-LRB-5-RRB-))
              (NNS:[926..931] cells))))))
    (,:[931..932] ,) (CC:[933..936] and)
    (S
      (NP-SBJ (DT:[937..940] the) (NN:[941..943] Km))
      (VP (VBD:[944..947] was)
        (NP-PRD (CD:[948..950] 98) (NN:[951..953] nM))))
    (.:[953..954] .)))

;sentence 10 Span:955..1162
;In neither minces nor cell cultures were we  able to show stimulation of
;aromatization with hCG, (Bu)2cAMP, or phorbol  esters, although we could show
;stimulation by these agents in normal testicular  cells.
;[1047..1050]:substance:"hCG"
;[1052..1061]:substance:"(Bu)2cAMP"
;[1066..1081]:substance:"phorbol  esters"
;[1127..1133]:substance:"agents"
(SENT
  (SINV
    (PP (IN:[955..957] In)
      (NP (CC:[958..965] neither)
        (NP (NNS:[966..972] minces))
        (CC:[973..976] nor)
        (NP (NN:[977..981] cell) (NNS:[982..990] cultures))))
    (VBD:[991..995] were)
    (NP-SBJ-1 (PRP:[996..998] we))
    (ADJP-PRD (JJ:[1000..1004] able)
      (S
        (NP-SBJ-1 (-NONE-:[1004..1004] *))
        (VP (TO:[1005..1007] to)
          (VP (VB:[1008..1012] show)
            (NP
              (NP (NN:[1013..1024] stimulation))
              (PP (IN:[1025..1027] of)
                (NP (NN:[1028..1041] aromatization)))
              (PP (IN:[1042..1046] with)
                (NP
                  (NP (NN:[1047..1050] hCG))
                  (,:[1050..1051] ,)
                  (NP (NN:[1052..1061] -LRB-Bu-RRB-2cAMP))
                  (,:[1061..1062] ,) (CC:[1063..1065] or)
                  (NP (NN:[1066..1073] phorbol) (NNS:[1075..1081] esters)))))))))
    (,:[1081..1082] ,)
    (SBAR-ADV (IN:[1083..1091] although)
      (S
        (NP-SBJ (PRP:[1092..1094] we))
        (VP (MD:[1095..1100] could)
          (VP (VB:[1101..1105] show)
            (NP
              (NP (NN:[1106..1117] stimulation))
              (PP (IN:[1118..1120] by)
                (NP (DT:[1121..1126] these) (NNS:[1127..1133] agents))))
            (PP-LOC (IN:[1134..1136] in)
              (NP (JJ:[1137..1143] normal) (JJ:[1144..1154] testicular)
                  (NNS:[1156..1161] cells)))))))
    (.:[1161..1162] .)))

;sentence 11 Span:1163..1269
;We were unable to inhibit the aromatase activity with human  beta-endorphin
;or stimulate it with naloxone.
;[1193..1202]:cyp450:"aromatase"
;[1224..1238]:substance:"beta-endorphin"
;[1260..1268]:substance:"naloxone"
(SENT
  (S
    (NP-SBJ (PRP:[1163..1165] We))
    (VP (VBD:[1166..1170] were)
      (ADJP-PRD (JJ:[1171..1177] unable)
        (S
          (NP-SBJ (-NONE-:[1177..1177] *))
          (VP (TO:[1178..1180] to)
            (VP
              (VP (VB:[1181..1188] inhibit)
                (NP (DT:[1189..1192] the) (NN:[1193..1202] aromatase)
                    (NN:[1203..1211] activity))
                (PP-MNR (IN:[1212..1216] with)
                  (NP (JJ:[1217..1222] human) (NN:[1224..1238] beta-endorphin))))
              (CC:[1239..1241] or)
              (VP (VB:[1242..1251] stimulate)
                (NP (PRP:[1252..1254] it))
                (PP-MNR (IN:[1255..1259] with)
                  (NP (NN:[1260..1268] naloxone)))))))))
    (.:[1268..1269] .)))

;sentence 12 Span:1270..1366
;However, we were able to inhibit  the aromatase activity with
;4-hydroxy-4-androstene-3,17-dione.
;[1308..1317]:cyp450:"aromatase"
;[1332..1365]:substance:"4-hydroxy-4-androstene-3,17-dione"
(SENT
  (S
    (ADVP (RB:[1270..1277] However))
    (,:[1277..1278] ,)
    (NP-SBJ (PRP:[1279..1281] we))
    (VP (VBD:[1282..1286] were)
      (ADJP-PRD (JJ:[1287..1291] able)
        (S
          (NP-SBJ (-NONE-:[1291..1291] *))
          (VP (TO:[1292..1294] to)
            (VP (VB:[1295..1302] inhibit)
              (NP (DT:[1304..1307] the) (NN:[1308..1317] aromatase)
                  (NN:[1318..1326] activity))
              (PP-MNR (IN:[1327..1331] with)
                (NP (NN:[1332..1365] 4-hydroxy-4-androstene-3,17-dione))))))))
    (.:[1365..1366] .)))

;sentence 13 Span:1367..1541
;We conclude that  the LTW(m) rat Leydig cell tumor has an active autonomous
;aromatase system that  is not responsive to compounds affecting the adenylate
;cyclase-cAMP system.
;[1443..1452]:cyp450:"aromatase"
;[1487..1496]:substance:"compounds"
;[1511..1528]:substance:"adenylate cyclase"
;[1529..1533]:substance:"cAMP"
(SENT
  (S
    (NP-SBJ (PRP:[1367..1369] We))
    (VP (VBP:[1370..1378] conclude)
      (SBAR (IN:[1379..1383] that)
        (S
          (NP-SBJ (DT:[1385..1388] the)
            (NML (NN:[1389..1392] LTW) (-LRB-:[1392..1393] -LRB-)
                 (NN:[1393..1394] m) (-RRB-:[1394..1395] -RRB-))
            (NN:[1396..1399] rat)
            (NML (NNP:[1400..1406] Leydig) (NN:[1407..1411] cell))
            (NN:[1412..1417] tumor))
          (VP (VBZ:[1418..1421] has)
            (NP
              (NP (DT:[1422..1424] an) (JJ:[1425..1431] active)
                  (JJ:[1432..1442] autonomous) (NN:[1443..1452] aromatase)
                  (NN:[1453..1459] system))
              (SBAR
                (WHNP-1 (WDT:[1460..1464] that))
                (S
                  (NP-SBJ-1 (-NONE-:[1464..1464] *T*))
                  (VP (VBZ:[1466..1468] is) (RB:[1469..1472] not)
                    (ADJP-PRD (JJ:[1473..1483] responsive)
                      (PP (TO:[1484..1486] to)
                        (NP
                          (NP (NNS:[1487..1496] compounds))
                          (VP (VBG:[1497..1506] affecting)
                            (NP (DT:[1507..1510] the)
                              (NML
                                (NML (NN:[1511..1520] adenylate)
                                     (NN:[1521..1528] cyclase))
                                (HYPH:[1528..1529] -) (NN:[1529..1533] cAMP))
                              (NN:[1534..1540] system))))))))))))))
    (.:[1540..1541] .)))

;sentence 14 Span:1542..1661
;It  can be inhibited by 4-hydroxy-4-androstene-3,17-dione, a
;competitive-suicide  inhibitor of the aromatase enzyme(s).
;[1566..1599]:substance:"4-hydroxy-4-androstene-3,17-dione"
;[1624..1633]:substance:"inhibitor"
;[1641..1660]:cyp450:"aromatase enzyme(s)"
(SENT
  (S
    (NP-SBJ-1 (PRP:[1542..1544] It))
    (VP (MD:[1546..1549] can)
      (VP (VB:[1550..1552] be)
        (VP (VBN:[1553..1562] inhibited)
          (NP-1 (-NONE-:[1562..1562] *))
          (PP (IN:[1563..1565] by)
            (NP-LGS
              (NP (NN:[1566..1599] 4-hydroxy-4-androstene-3,17-dione))
              (,:[1599..1600] ,)
              (NP
                (NP (DT:[1601..1602] a)
                  (NML (JJ:[1603..1614] competitive) (HYPH:[1614..1615] -)
                       (NN:[1615..1622] suicide))
                  (NN:[1624..1633] inhibitor))
                (PP (IN:[1634..1636] of)
                  (NP (DT:[1637..1640] the)
                     (NN:[1641..1650] aromatase)
                     (NN:[1651..1660] enzyme-LRB-s-RRB-)))))))))
    (.:[1660..1661] .)))

;section 15 Span:1665..1708
;PMID: 3030702 [PubMed - indexed for MEDLINE
(SEC
  (FRAG (NNP:[1665..1669] PMID) (::[1669..1670] :) (CD:[1671..1678] 3030702)
        (-LRB-:[1679..1680] -LSB-) (NNP:[1680..1686] PubMed) (::[1687..1688] -)
        (NN:[1689..1696] indexed) (IN:[1697..1700] for)
        (NNP:[1701..1708] MEDLINE)))
;ERROR_Orphan Text from EOF Tree File[1708..EOF] ]

(ORPH -RSB-)
